Alameda, CA, United States of America

Nicole Fay

This inventor holds 3 USPTO granted patents. Top assignee: Nutcracker Therapeutics, Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicole Fay. Retrieved from https://idiyas.com/inventor/nicole-fay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Nicole Fay

Introduction

Nicole Fay is a prominent inventor based in Alameda, CA, known for her contributions to the field of biotechnology. With a total of two patents to her name, she has made significant strides in developing innovative treatments that harness the power of mRNA technology.

Latest Patents

Nicole's latest patents focus on mRNA treatment nanoparticles. These patents provide examples of mRNA treatment nanoparticles and methods for using them to treat patients. An mRNA treatment nanoparticle may include one or more mRNAs encoding a tumor-specific antigen and an immunomodulatory agent, along with a delivery vehicle molecule that encapsulates the mRNAs.

Career Highlights

Nicole Fay is currently associated with Nutcracker Therapeutics, Inc., where she continues to advance her research and development efforts in the field of mRNA technology. Her work is pivotal in exploring new therapeutic avenues for cancer treatment.

Collaborations

Some of her notable coworkers include Samuel Deutsch and Daniel Frimannsson, who collaborate with her on various projects within the company.

Conclusion

Nicole Fay's innovative work in mRNA treatment nanoparticles exemplifies the potential of biotechnology to revolutionize patient care. Her contributions are paving the way for new therapeutic strategies in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…